temoblast TEMOZOLOMIDE

Introduction to temoblast

Temoblast is a medication primarily used in the treatment of certain aggressive brain tumors. It is available in tablet form and is specifically used for conditions like glioblastoma multiforme and anaplastic astrocytoma. Temoblast works by targeting cancer cells in the brain.

Composition of temoblast

Temoblast contains the active ingredient Temozolomide, which is an alkylating agent. This compound interferes with the DNA of cancer cells, preventing their growth and division, thereby helping to control the spread of cancer.

Uses of temoblast

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temoblast

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of temoblast

Patients using temoblast should be aware that it can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Those with severe bone marrow suppression should avoid using this medication.

How to Take temoblast

Temoblast is taken orally, usually on an empty stomach, either one hour before or two hours after a meal. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of temoblast

Temoblast, containing the active ingredient Temozolomide, belongs to the therapeutic class of alkylating agents. It is primarily used to treat aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Manufactured by leading pharmaceutical companies, temoblast is a critical medication in oncology. Always consult with a healthcare professional for proper guidance on its use.